Hepatitis C virus seroprevalence in The Netherlands | Zendy

Henrike J. Vriend | Zendy; Eline Op de Coul | Zendy; Thijs van de Laar | Zendy; Anouk T. Urbanus | Zendy; Fiona van der Klis | Zendy; Hein J. Boot | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hepatitis C virus seroprevalence in The Netherlands

Author(s) -

Henrike J. Vriend,

Eline Op de Coul,

Thijs van de Laar,

Anouk T. Urbanus,

Fiona van der Klis,

Hein J. Boot

Publication year - 2012

Publication title -

european journal of public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.056

H-Index - 91

eISSN - 1464-360X

pISSN - 1101-1262

DOI - 10.1093/eurpub/cks013

Subject(s) - seroprevalence , medicine , confidence interval , hepatitis c virus , population , virology , hepatitis c , environmental health , hepatitis a virus , cross sectional study , disease burden , hepatitis a , demography , virus , immunology , hepatitis , serology , antibody , pathology , sociology

A population-based anti-hepatitis C virus (HCV) prevalence is important for surveillance purposes and it provides an insight into the burden of disease. In The Netherlands, a recent HCV seroprevalence estimate is not available. This national population-based cross-sectional serosurvey (PIENTER-2) resulted in a weighted national HCV seroprevalence of 0.30% (95% confidence interval 0.05-0.55%). About 70% of the HCV positive individuals found were born in an HCV-endemic country.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research